Ginkgo bioworks strengthens end-to-end r&d capabilities in gene therapy through acquisition of stridebio's aav capsid discovery and engineering platform assets
Platform includes large library of existing capsids, which have been optimized for performance and targeting across a range of application areas through validation in large animal models the addition of stridebio's structure-guided aav engineering capabilities combined with ginkgo's already extensive assets make ginkgo a unique one-stop shop capable of providing r&d services for gene therapy manufacturing across capsid, payload, and cell line optimization as part of the transaction, ginkgo also receives ip and data for stridebio's lead preclinical asset for arrhythmogenic right ventricular cardiomyopathy, a rare genetic heart disease, which ginkgo plans to sell or outlicense to a commercial partner boston , april 5, 2023 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced the acquisition of stridebio's adeno-associated virus (aav) capsid discovery and engineering platform assets with a secondary close scheduled upon the transfer of certain additional in-license agreements to ginkgo. ginkgo will incorporate these capabilities and ip into its end-to-end aav gene therapy development platform, allowing ginkgo's customers to leverage new tools to effectively target many different tissue types, and potentially to improve the safety profile of their future gene therapies.
DNA Ratings Summary
DNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission